Kamarck Michael E.
SEC-identified person · CIK 1450730 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Vaxcyte, Inc. PCVX | Director | filed 2021–2023 |
| Passage BIO, Inc. PASG | Director | filed 2022–2023 |
| Trillium Therapeutics Inc. TRIL | Director | filed 2021–2021 |
| Vir Biotechnology, Inc. VIR | Chief Technology Officer | filed 2019–2019 |
| Unilife Corp UNIS | Director | filed 2016–2016 |
| Omni BIO Pharmaceutical, INC. ombp | Director | filed 2013–2013 |
| Wyeth WYE | President, TO&PS | filed 2008–2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.